These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5308658)

  • 21. Temporal bone histopathology in human ototoxicity due to loop diuretics.
    Arnold W; Nadol JB; Weidauer H
    Scand Audiol Suppl; 1981; 14 Suppl():201-13. PubMed ID: 6949281
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction of kanamycin and ethacrynic acid. Severe cochlear damage in guinea pigs.
    West BA; Brummett RE; Himes DL
    Arch Otolaryngol; 1973 Jul; 98(1):32-7. PubMed ID: 4713139
    [No Abstract]   [Full Text] [Related]  

  • 23. Disturbances in the central vestibular system after oral contraceptives.
    Peitersen E
    J Laryngol Otol; 1969 Jul; 83(7):725-9. PubMed ID: 5306191
    [No Abstract]   [Full Text] [Related]  

  • 24. [Temporary vestibular loss following local anaesthesia of the ear (author's transl)].
    Lemke T
    Laryngol Rhinol Otol (Stuttg); 1977 Jul; 56(7):623-5. PubMed ID: 142881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced true vertigo and balance disorders.
    Prescrire Int; 2015 Jan; 24(156):18. PubMed ID: 25729826
    [No Abstract]   [Full Text] [Related]  

  • 26. Ethacrynic acid ototoxicity potentiation by kanamycin.
    Prazma J; Browder JP; Fischer ND
    Ann Otol Rhinol Laryngol; 1974; 83(1):111-8. PubMed ID: 4811573
    [No Abstract]   [Full Text] [Related]  

  • 27. Hazards of ethacrynic acid.
    Merrill JP
    JAMA; 1970 Apr; 212(1):159. PubMed ID: 5467219
    [No Abstract]   [Full Text] [Related]  

  • 28. Hazards of ethacrynic acid.
    Chaffee WG
    JAMA; 1970 Apr; 212(1):159. PubMed ID: 5467218
    [No Abstract]   [Full Text] [Related]  

  • 29. Transient and permanent deafness following treatment with ethacrynic acid in renal failure.
    Pillay VK; Schwartz FD; Aimi K; Kark RM
    Lancet; 1969 Jan; 1(7585):77-9. PubMed ID: 4178003
    [No Abstract]   [Full Text] [Related]  

  • 30. [Transient deafness and ethacrynic acid. Possible role of the changes in the composition of cochlear fluids].
    Barjon P; Fourcade J; Mimran A
    Sem Hop; 1972 Mar; 48(14):993-6. PubMed ID: 4339078
    [No Abstract]   [Full Text] [Related]  

  • 31. Deafness after ethacrynic acid.
    Homer MJ
    N Engl J Med; 1971 Nov; 285(20):1152. PubMed ID: 5095755
    [No Abstract]   [Full Text] [Related]  

  • 32. Ototoxicity of ethacrynic acid (a persistent clinical problem).
    Rybak LP
    J Laryngol Otol; 1988 Jun; 102(6):518-20. PubMed ID: 3294319
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bilateral deafness due to the local use of framycetin (author's transl)].
    Renou G; Sénéchal G; Sterkers JM
    Ann Otolaryngol Chir Cervicofac; 1978; 95(10-11):691-4. PubMed ID: 312051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ototoxicity of ethacrynic acid. Demonstrated in a human temporal bone.
    Matz GJ; Beal DD; Krames L
    Arch Otolaryngol; 1969 Aug; 90(2):152-5. PubMed ID: 5794874
    [No Abstract]   [Full Text] [Related]  

  • 35. The ototoxicity of gentamicin.
    Tjernström O; Banck G; Belfrage S; Juhlin I; Nordström L; Toremalm NG
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973; ():Suppl 241:73-8. PubMed ID: 4544328
    [No Abstract]   [Full Text] [Related]  

  • 36. [Transient deafness during ethacrynic acid therapy].
    Iványi J
    Orv Hetil; 1971 May; 112(21):1225-6. PubMed ID: 5090426
    [No Abstract]   [Full Text] [Related]  

  • 37. Early changes in the cochlear duct from ethacrynic acid: an electronmicroscopie evaluation.
    Quick CA; Duvall AJ
    Laryngoscope; 1970 Jun; 80(6):954-65. PubMed ID: 5426728
    [No Abstract]   [Full Text] [Related]  

  • 38. Vestibulotoxicity of ethacrynic acid.
    Mathog RH
    Laryngoscope; 1977 Nov; 87(11):1791-1808. PubMed ID: 303321
    [No Abstract]   [Full Text] [Related]  

  • 39. [Transient deafness-a rare complication of ethacrynic acid therapy].
    Paloheimo JA
    Duodecim; 1968; 84(1):48-50. PubMed ID: 5666341
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical features of cisplatin vestibulotoxicity and hearing loss.
    Kobayashi H; Ohashi N; Watanabe Y; Mizukoshi K
    ORL J Otorhinolaryngol Relat Spec; 1987; 49(2):67-72. PubMed ID: 3496573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.